ADIPOQ and type 2 diabetes mellitus: Generally, circulating leptin concentrations are higher in obesity and metabolic syndromes, including type 2 diabetes, hypertension, or dyslipidemia, in conjunction with a decrease in adiponectin levels in the blood [20].